Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernst Peter Allhoff

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Aktuelle Urologie|February 2, 2018
Frank Steinbach, Fred Schuster, Ernst Peter Allhoff
Aktuelle Urologie|February 6, 2025
Frank Steinbach, Fred Schuster, Ernst Peter Allhoff
Aktuelle Urologie|August 3, 2022
Frank Steinbach, Fred Schuster, Ernst Peter Allhoff
The Prostate|January 13, 2004
Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancerJens Ekkehard König, Theodor Senge, Ernst Peter Allhoff, et al.
The Journal of Urology|November 21, 2002
Loss of heterozygosity on chromosome 5p13-12 predicts adverse prognosis in advanced bladder cancer independent of tumor stage and gradeMalte Böhm, Ilse Wieland, Claus Schmidt, et al.
BJU International|April 13, 2007
Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinomaTobias Klatte, Malte Böhm, Thomas Nelius, et al.
Onkologie|February 13, 2008
Pretreatment with interferon-alpha2a modulates perioperative immunodysfunction in patients with renal cell carcinomaTobias Klatte, Annelore Ittenson, Friedrich-Wilhelm Röhl, et al.
Onkologie|October 27, 2005
Characterization of prognostic factors and efficacy in a phase-II study with docetaxel and estramustine for advanced hormone refractory prostate cancerThomas Nelius, Frank Reiher, Tobias Lindenmeir, et al.
Urologic Oncology|March 28, 2008
Pathobiology and prognosis of chromophobe renal cell carcinomaTobias Klatte, Ken-ryu Han, Jonathan W Said, et al.
The Journal of Urology|March 18, 2008
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomasTobias Klatte, Jean-Jacques Patard, Michela de Martino, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Aktuelle Urologie|February 2, 2018
Frank Steinbach, Fred Schuster, Ernst Peter Allhoff
Aktuelle Urologie|February 6, 2025
Frank Steinbach, Fred Schuster, Ernst Peter Allhoff
Aktuelle Urologie|August 3, 2022
Frank Steinbach, Fred Schuster, Ernst Peter Allhoff
The Prostate|January 13, 2004
Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancerJens Ekkehard König, Theodor Senge, Ernst Peter Allhoff, et al.
The Journal of Urology|November 21, 2002
Loss of heterozygosity on chromosome 5p13-12 predicts adverse prognosis in advanced bladder cancer independent of tumor stage and gradeMalte Böhm, Ilse Wieland, Claus Schmidt, et al.
BJU International|April 13, 2007
Evaluation of peri-operative peripheral and renal venous levels of pro- and anti-angiogenic factors and their relevance in patients with renal cell carcinomaTobias Klatte, Malte Böhm, Thomas Nelius, et al.
Onkologie|February 13, 2008
Pretreatment with interferon-alpha2a modulates perioperative immunodysfunction in patients with renal cell carcinomaTobias Klatte, Annelore Ittenson, Friedrich-Wilhelm Röhl, et al.
Onkologie|October 27, 2005
Characterization of prognostic factors and efficacy in a phase-II study with docetaxel and estramustine for advanced hormone refractory prostate cancerThomas Nelius, Frank Reiher, Tobias Lindenmeir, et al.
Urologic Oncology|March 28, 2008
Pathobiology and prognosis of chromophobe renal cell carcinomaTobias Klatte, Ken-ryu Han, Jonathan W Said, et al.
The Journal of Urology|March 18, 2008
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomasTobias Klatte, Jean-Jacques Patard, Michela de Martino, et al.
Pageof 2